BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21315423)

  • 21. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
    Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
    Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SHP-1 expression by malignant small B-cell lymphomas reflects the maturation stage of their normal B-cell counterparts.
    Kossev PM; Raghunath PN; Bagg A; Schuster S; Tomaszewski JE; Wasik MA
    Am J Surg Pathol; 2001 Jul; 25(7):949-55. PubMed ID: 11420468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.
    Kunder CA; Roncador G; Advani RH; Gualco G; Bacchi CE; Sabile JM; Lossos IS; Nie K; Tibshirani RJ; Green MR; Alizadeh AA; Natkunam Y
    Am J Clin Pathol; 2017 Nov; 148(6):465-476. PubMed ID: 29140403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
    Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
    Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the diffuse B-cell lymphoma family molecule SWAP-70 in human B-cell neoplasms: immunohistochemical study of 86 cases.
    Heerema AE; Abbey NW; Weinstein M; Herndier BG
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):21-5. PubMed ID: 15163014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.
    Dorfman DM; Brown JA; Shahsafaei A; Freeman GJ
    Am J Surg Pathol; 2006 Jul; 30(7):802-10. PubMed ID: 16819321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
    Shams TM
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma.
    Omodei D; Acampora D; Russo F; De Filippi R; Severino V; Di Francia R; Frigeri F; Mancuso P; De Chiara A; Pinto A; Casola S; Simeone A
    Am J Pathol; 2009 Dec; 175(6):2609-17. PubMed ID: 19893048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
    Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
    Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
    Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
    Natkunam Y; Lossos IS; Taidi B; Zhao S; Lu X; Ding F; Hammer AS; Marafioti T; Byrne GE; Levy S; Warnke RA; Levy R
    Blood; 2005 May; 105(10):3979-86. PubMed ID: 15677569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
    Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
    Yin H; Okada N; Takagi M
    J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.